Abstract | BACKGROUND AND AIMS: METHODS AND RESULTS: A total of 2265 consecutive patients with DM and ACS were eligible in the study. Patients were divided into four groups according to quartiles of D-dimer concentration. Univariate and multivariate Cox regression analysis were conducted to explore the prognostic value of D-dimer for future outcomes. Patients with higher level of D-dimer presented with higher percentage of major adverse cardiovascular events (MACEs) (23.7%), all-cause death (18.3%) and cardiovascular (CV) death (9.4%) in Quartile 4. In multivariate Cox regression analysis, D-dimer was demonstrated to be independently associated with MACEs, all-cause death and CV death. The prognostic value of D-dimer is still significant in subgroups of HbA1C <7% and ≥7%. In Kaplan-Meier analysis, higher D-dimer showed poorer prognosis in MACEs, all-cause death and CV death (all log rank p < 0.001). The area under the curve (AUC) by receiver operating characteristic (ROC) curve analysis is 0.609 for MACEs, 0.708 for all-cause death, 0.747 for CV death (p < 0.001). CONCLUSION: The present study demonstrated the independent predictive value of D-dimer for outcomes in DM patients with ACS. In addition, for the first time, we explored the prognostic value in different glucose control status.
|
Authors | Bing-Yang Zhou, Qi Zhang, Yue-Cheng Hu, Lin Wang, Jing-Xia Zhang, Hong-Liang Cong, Le Wang |
Journal | Nutrition, metabolism, and cardiovascular diseases : NMCD
(Nutr Metab Cardiovasc Dis)
Vol. 32
Issue 8
Pg. 1955-1962
(08 2022)
ISSN: 1590-3729 [Electronic] Netherlands |
PMID | 35752544
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Biomarkers
- Fibrin Fibrinogen Degradation Products
- fibrin fragment D
|
Topics |
- Acute Coronary Syndrome
(diagnosis, epidemiology)
- Biomarkers
- Diabetes Mellitus
(epidemiology)
- Diabetes Mellitus, Type 2
(complications, diagnosis)
- Fibrin Fibrinogen Degradation Products
(chemistry)
- Humans
- Prognosis
- Risk Assessment
- Risk Factors
|